Onco-Innovations highlights three key aspects of the studies: the nanoparticle formulation of the PNKP compound's ability to target cancer site; the effectiveness of this formulation as a standalone ...

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering ...

VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Onco-Innovations Limited (ONCO:CA)(Frankfurt:W1H)(WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")is pleased ...

Pertuzumab/Docetaxel/Carboplatin/Trastuzumab Regimen in Human Epidermal Growth Factor Receptor 2–Positive Early, Locally Advanced, and Oligometastatic Breast Cancer ...

Initial results were announced today from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early ...

The investigators reported the results of a prospective, randomized, phase 3 trial studying the best individual therapy for women who have node-negative, estrogen-receptor‒positive (ER-positive) ...

Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended the expanded use of ...

TAMPA, Fla., Jan. 16, 2025 /PRNewswire/ -- ONCO Inc. ("ONCO") and Inspirata Inc. ("Inspirata") have announced a strategic partnership to advance oncology data management and support innovative cancer ...

For patients with acute coronary syndrome (ACS) and cancer, the ONCO-ACS score predicts mortality, bleeding, and ischemic risk.

Dec. 09, 2025 6:00 PM ETOnco-Innovations Limited (ONCO:CA) "This fourth roundtable marks a pivotal moment as we are moving from vision to actionable roadmaps that will make precision oncology ...

The June 2021 study showed that Onco's nanoparticle formulation of PNKP inhibitors effectively slowed the growth of cancer cells in colorectal cancer-bearing mice. The study reported an in vitro and ...